Labcorp on Tuesday raised its annual profit forecast and beat estimates in the third quarter as the laboratory operator ...

Labcorp delivered mixed third-quarter results, with higher sales and raised profit | Labcorp reported solid third-quarter ...

Labcorp boosted its 2025 adjusted per-share earnings target to a range between $16.15 and $16.50 a share from a prior projection of $16.05 to $16.50. The diagnostic testing company cut its revenue ...

Guidance Updates -- Full-year 2025 revenue growth guidance was narrowed to 7.4%-8%, with Adjusted EPS guidance was set at $16 ...

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) in Q3 CY2025, with sales up 8.6% year on year to $3.56 billion. Its ...

While the top- and bottom-line numbers for Labcorp (LH) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare ...

The medical laboratory operator posted revenue of $3.56 billion in the period, which matched Street forecasts. Labcorp expects full-year earnings in the range of $16.15 to $16.50 per share.

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be reporting results this Tuesday before market open. Here’s ...

Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...

Labcorp, one of the country’s largest providers of diagnostic medical testing services, announced today that it will offer ...

Updates Full-Year Guidance Financial results from Operations for third quarter 2025 versus third quarter 2024: Revenue: $3.56 billion versus $3.28 billion ...

Investing.com - Labcorp Holdings (NYSE: LH) reported third quarter EPS of $4.18, $0.05 better than the analyst estimate of $4.13. Revenue for the quarter came in at $3.56B versus the consensus ...